@article{CCO15429,
author = {Priya K. Simoes and Sara H. Olson and Amethyst Saldia and Robert C. Kurtz},
title = {Epidemiology of pancreatic adenocarcinoma},
journal = {Chinese Clinical Oncology},
volume = {6},
number = {3},
year = {2017},
keywords = {},
abstract = {Pancreatic ductal adenocarcinoma is one of the most lethal cancers worldwide. The highest incidence rates her found are in North America and in Western Europe while lower rates in Asian Africa, with age standard incidence rates of 7.2 and 2.8 per 100,000 populations. Unfortunately the vast majority of individuals with pancreatic cancer present with symptoms, and once symptoms develop the chance for surgery is only about 20%. Additionally he incidence rate and mortality from pancreatic ductal adenocarcinoma in the United States shows a very close association suggesting that her earlier detection and treatment does little to change the outcome from this disease. Multiple of environmental and genetic risk factors have been implicated in the development of pancreatic ductal adenocarcinoma. We have reviewed those risk factors we believe are most important the development of this lethal disease. It is hoped that in the future, identification of biomarkers unique in the development of pancreatic ductal adenocarcinoma will be identified leading to earlier detection and a greater frequency of potential cure of this disease.},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/15429}
}